Financial Summary for the First Quarter of the Fiscal Year Ending May 2027 [Japanese GAAP] (Consolidated)

Overview of Results

For the first quarter of the fiscal year ending May 2027, COSMOS Pharmaceutical Corporation reported net sales of 286,653 million yen, operating income of 12,005 million yen, ordinary income of 12,766 million yen, and net income attributable to owners of parent of 8,251 million yen. Compared with the same quarter of the previous fiscal year, net sales increased 5.2%, operating income increased 3.1%, ordinary income increased 4.7%, and net income increased 1.0%, showing steady performance. The company actively opened new stores, adding 13 stores across Tohoku, Kanto, Chubu, Kansai, and Kyushu regions, while closing 4 stores. The number of stores at the end of the first quarter was 1,717.

Outlook and Dividends

The full-year earnings forecast remains unchanged from the previous release, with projections of net sales of 1,190,000 million yen, operating income of 43,000 million yen, ordinary income of 45,700 million yen, and net income attributable to owners of parent of 30,700 million yen. Earnings per share are forecast at 387.35 yen. The dividend forecast remains the same as the prior fiscal year; no dividends for the first quarter-end or second quarter-end have been announced.